Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.
Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).
1.诺和诺德司美格鲁肽在中国获批用于长期体重管理
2.将限制减肥药Wegovy在华供应量 以避免全球供应中断
阅读原文
